Why Composition and Preparation Matter
Why the same cannabis plant can lead to very different products and effects, covering composition, preparation, route of use and labels, with sources and no instructions.
Content last updated . This page has not been medically reviewed.
One plant, many different products
The phrase "cannabis" can mean dried flower, an oil, a gummy, a lotion, a vape liquid or a prescription medicine. They do not behave alike. NIDA says cannabis may affect people differently depending on the amount taken, THC potency, a product's ingredients, the way it is ingested, other drugs a person has taken, underlying medical conditions, and age, sex and genetic differences. [1] This page explains four things that change what a product does: composition, preparation, route and label accuracy. It gives no dosing, recipes or preparation steps.Composition: what is in the product
Cannabis chemistry varies from sample to sample. A study of commercial cannabis from six US states found distinct chemical profiles (chemotypes), and that the labels used in the market do not consistently line up with them. [2] Plants also fall into broad chemotypes, defined by the ratio of THC to CBD: THC-predominant, CBD-predominant and intermediate. [3]Some points follow:
- A cultivar name, an indica or sativa label, or a lineage claim is not a chemical measurement. See Why Indica and Sativa Labels Do Not Reliably Predict Effects.
- Marketing percentages are not the same as independent laboratory results. Because composition varies, this site gives no "typical" THC, CBD or terpene percentages. Verified batch data would be needed for any specific product. See How to Read a Cannabis COA.
- Extra ingredients matter. A hemp-derived oral product with CBD, THC and their acid forms produced subjective intoxication and impaired working memory in a laboratory study at its highest study amount, even though its THC content was relatively low. [4]
Preparation: how the starting material was changed
Plant material and extracts can be turned into oils, edibles, concentrates and topical products. Processing changes what a product contains, such as how much of a cannabinoid is in acid or neutral form. [5] Heat, light and air alter cannabinoid acids over time. [6] See Decarboxylation Explained. Different product families are in their own collections, such as Cannabis Concentrates Explained and CBD Products: Oils, Topicals, Edibles and How to Read a Label.Route: how it enters the body
The same compound acts differently depending on how it is taken. These are published findings about timing, not guidance.| Route | What a pharmacology review reports | Source |
|---|---|---|
| Inhaled | Peak THC in blood within minutes; effects start within seconds to a few minutes and fade within about 2 to 3 hours | [7] |
| Swallowed | Effects start 30 to 90 minutes later and can last about 4 to 12 hours | [7] |
| Smoked vs swallowed | THC bioavailability averages about 30 percent when smoked versus 4 to 12 percent by mouth, with highly variable absorption by mouth | [8] |
NIDA says edibles typically take longer to show effects, and that people may use more as a result, increasing the likelihood of serious negative effects. [1] NIDA also says dabbing can rapidly deliver large amounts of THC. [1] See Delayed Effects and Accidental Overconsumption of Edibles.
Label accuracy
NCCIH says some cannabis and cannabinoid products contain amounts that differ substantially from their labels, and reports of contamination with microorganisms, pesticides or other substances. [9] FDA tested some CBD products and found many did not contain the amount of CBD claimed. [10] Products marketed as CBD have also been found to contain THC. [1]Medicines versus consumer products
FDA says approved drugs have been carefully evaluated for safety, efficacy and quality, [11] and the approved CBD medicine is a purified product. [9] Consumer products do not carry that guarantee. See Cannabis Medicines vs Consumer Products.Safety note
Because product contents and routes vary, the amount that is too much for one person or product cannot be read from a label alone. If a child has swallowed a cannabis product, FDA says to take the child to a physician or emergency department. [11] In the US, call 911 or Poison Help at 1-800-222-1222.Frequently asked questions
Why do two products with the same cultivar name feel different?
A name is not a chemical measurement. Composition varies from sample to sample, and market labels do not consistently match measured chemical profiles. [2]
Does the route of use change the effect?
Yes. For THC, inhaled and swallowed routes differ in how quickly effects begin and how long they last. [7]
Why do edibles feel delayed?
NIDA says edibles typically take longer to show effects. [1] The delay is a reason overconsumption is a risk.
Can I trust the percentage on a label?
Not on its own. Labels can differ from what is in the product, [9] so independent batch test data is the better check.
Are CBD products the same as the prescription CBD medicine?
No. The approved medicine is a regulated drug with a defined formulation; over-the-counter products may contain more or less CBD than labeled. [9]
References
- National Institute on Drug Abuse (NIDA). Cannabis (Marijuana) DrugFacts. Read 2026-10-22.
- Smith CJ et al.. The phytochemical diversity of commercial Cannabis in the United States. PLoS One. 2022. PubMed abstract read 2026-10-22.
- Borroto Fernandez E et al.. Distribution of Chemical Phenotypes (Chemotypes) in European Agricultural Hemp (Cannabis sativa L.) Cultivars. J Forensic Sci. 2020. PubMed abstract read 2026-10-22.
- Elder HJ et al.. The Pharmacokinetics and Pharmacodynamics of a Hemp-Derived "Full-Spectrum" Oral Cannabinoid Product with a 1:1 Ratio of Cannabidiol to Cannabidiolic Acid and Delta-9-Tetrahydrocannabinol to Delta-9-Tetrahydrocannabinolic Acid: A Double-Blind, Placebo-Controlled, Within-Subjects Human Laboratory Study. Cannabis Cannabinoid Res. 2025. PubMed abstract read 2026-10-22.
- Filer CN. Acidic Cannabinoid Decarboxylation. Cannabis Cannabinoid Res. 2022. PubMed abstract read 2026-10-22.
- Citti C et al.. Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics studies of cannabidiolic acid (CBDA). J Pharm Biomed Anal. 2018. PubMed abstract read 2026-10-22.
- Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003. PubMed abstract read 2026-10-22.
- McGilveray IJ. Pharmacokinetics of cannabinoids. Pain Res Manag. 2005. PubMed abstract read 2026-10-22.
- National Center for Complementary and Integrative Health (NCCIH). Cannabis (Marijuana) and Cannabinoids: What You Need To Know. Read 2026-10-22.
- US Food and Drug Administration. What You Need to Know (And What We're Working to Find Out) About Products Containing Cannabis or Cannabis-derived Compounds, Including CBD. FDA page states content current as of 03/05/2020. Read 2026-10-22.
- US Food and Drug Administration. FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD): Questions and Answers. FDA page states content current as of 07/16/2024. Read 2026-10-22.